Late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.

Abstract

BACKGROUND Low plasma levels of erythropoietin (EPO) in preterm infants provide a rationale for the use of EPO to prevent or treat anaemia. OBJECTIVES To assess the effectiveness and safety of late initiation of EPO (initiated at eight days after birth or later) in reducing the use of red blood cell (RBC) transfusions in preterm and/or low birth weight… (More)
DOI: 10.1002/14651858.CD004863.pub3

Topics

1 Figure or Table

Cite this paper

@article{Aher2006LateEF, title={Late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.}, author={Sanjay M Aher and Arne Ohlsson}, journal={The Cochrane database of systematic reviews}, year={2006}, volume={4}, pages={CD004868} }